Loading...
Indian Pharmaceutical Exporter · #2 for Mefloquine · $116.7K export value · DGFT Verified
Kalindi Overseas is the #2 Indian exporter of Mefloquine with $116.7K in export value and 22 verified shipments. Kalindi Overseas holds a 4.8% market share in Mefloquine exports across 6 countries. The company exports 5 pharmaceutical products worth $228.0K across 3 therapeutic categories.
| $1.2K |
| 2 |
| 1.0% |
| PANAMA | $404 | 1 | 0.3% |
Kalindi Overseas exports Mefloquine to 6 countries. The largest destination is GREECE accounting for 43.5% of Kalindi Overseas's Mefloquine shipments, followed by UNITED STATES (28.0%) and SINGAPORE (15.4%). These destinations reflect Kalindi Overseas's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO.THE PURCHASE DEPARTMENT | GREECE | $36.1K | 7 |
| THE PURCHASE DEPARTMENT | BARBADOS | $32.7K | 4 |
| PURCHASE DEPARTMENT | SINGAPORE | $18.0K | 2 |
| TO THE PURCHASE DEPARTMENT | GREECE | $14.7K | 3 |
| TO THE PURCHASE DEPARTMENT.. | UNITED KINGDOM | $9.2K | 2 |
| PURCHASE DEPARTMENT UNIVERSAL MARINE MEDICAL LIMITED | UNITED KINGDOM | $3.1K | 1 |
| TO THE PURCHASE DEPARMENT | UNITED KINGDOM | $1.5K | 1 |
| THE PURCHASE DEPARTMENT ARMSTRONG HEALTH | BARBADOS | $1.1K | 1 |
Kalindi Overseas supplies Mefloquine to 8 buyers globally. The largest buyer is TO.THE PURCHASE DEPARTMENT (GREECE), followed by THE PURCHASE DEPARTMENT (BARBADOS) and PURCHASE DEPARTMENT (SINGAPORE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $907.4K worth of Mefloquine through 265 shipments from 75 suppliers to 56 countries, serving 118 buyers globally. Kalindi Overseas contributes $116.7K to this total, accounting for 4.8% of India's Mefloquine exports. Kalindi Overseas ships Mefloquine to 6 countries through 8 buyers.
Kalindi Overseas's average Mefloquine shipment value is $5.3K per consignment, based on 22 shipments totaling $116.7K. The largest destination is GREECE (43.5% of Kalindi Overseas's Mefloquine exports).
Kalindi Overseas ranks #2 among 75 Indian Mefloquine exporters with a 4.8% market share. The top 3 exporters are CIPLA LIMITED ($550.0K), KALINDI OVERSEAS ($116.7K), YASHICA PHARMACEUTICALS PRIVATE LIMITED ($83.0K). Kalindi Overseas processed 22 shipments to 6 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| MEFLOQUINE TABS 250MG | $67.2K | 9 |
| MEFLOQUINE 250MG TABLET | $18.7K | 5 |
| MEFLOQUINE 250MG TAB | $9.3K | 1 |
| MEFLOQUINE TABS 250MG | $6.3K | 1 |
| OTHER MEDICAMENTS(MEFLOQUINE 250MG TAB) | $6.1K | 1 |
| MEFLOQUINE TAB 250MG | $6.0K | 1 |
| PHARMACEUTICALS - Mefloquine 250mg Tablet | $1.5K | 1 |
| MEFLOQUINE 250MG TABLETS | $1.1K | 1 |
| PHARMACEUTICALS - MEFLOQUINE HCL 250MG TAB, BRAND: MEFLOTAS, PACK: 2 TAB, BATCHNO. K2400272 (INJ=NOS) | $404 | 1 |
| OTHER MEDICAMENT (MEFLOQUINE HCL 250MG T | $98 | 1 |
Kalindi Overseas exports 10 distinct Mefloquine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MEFLOQUINE TABS 250MG with 9 shipments worth $67.2K.
What Kalindi Overseas must comply with to export Mefloquine to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | CIPLA LIMITED | $550.0K | 11 | 5 | $50.0K |
| 2 | KALINDI OVERSEAS ★ | $116.7K | 22 | 6 | $5.3K |
| 3 | YASHICA PHARMACEUTICALS PRIVATE LIMITED | $83.0K | 8 | 5 | $10.4K |
| 4 | ARVINCARE | $51.1K | 7 | 1 | $7.3K |
Kalindi Overseas ranks #2 among 75 Indian Mefloquine exporters. Average shipment value of $5.3K compared to the market average of $12.1K. The closest competitors by value are CIPLA LIMITED and YASHICA PHARMACEUTICALS PRIVATE LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 107 | 40.4% |
| SAHAR AIR | 59 | 22.3% |
| Bombay Air | 20 | 7.5% |
| DELHI AIR | 12 | 4.5% |
| Bombay Air Cargo | 12 | 4.5% |
| AHEMDABAD AIR | 8 | 3.0% |
| Delhi Air | 7 | 2.6% |
| DELHI AIR CARGO ACC (INDEL4) | 5 | 1.9% |
Kalindi Overseas also exports these antimalarial & antiparasitic products. Each links to the detailed product page.
Kalindi Overseas exports 5 products worth $228.0K. Beyond Mefloquine, top products include Proguanil, Atovaquone, Ibrutinib, Volini. View the complete Kalindi Overseas profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Mefloquine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 56+ countries, 118+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Kalindi Overseas's Mefloquine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Kalindi Overseas
Full Company Profile →
5 products · $228.0K total trade · 3 categories
Access shipment-level records, pricing trends, and buyer contacts for Kalindi Overseas.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Mefloquine. For current shipment-level data, contact TransData Nexus.